Top shares for October

We asked our writers to share their top stock picks for the month.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We asked our writers to share their top stock picks for the month of October, and this is what they had to say:


Kevin Godbold: Smith & Nephew

The FTSE 100’s Smith & Nephew (LSE: SN) makes joint replacements for knees, hips and shoulders, tools for minimally invasive surgery, and other medical bits and pieces. It’s a ‘defensive’ business characterised by steady demand, and that shows in the firm’s record of well-balanced growth in revenue, cash flow and earnings.

Cash flow supports profits well, and City analysts expect high single-digit advances in earnings going forward. You are unlikely to pick up shares in a firm with such attraction at bargain-basement levels, but ongoing operational progress looks set to drive the shares higher, perhaps as early as during October.

Kevin Godbold does not own shares in Smith & Nephew.


Rupert Hargreaves: Galliford Try

In the first half of 2018, the market fell out of love with homebuilder Galliford Try (LSE: GFRD). However, it now looks as if confidence is returning, with the stock up just under 20% over the past six months excluding dividends, compared to the FTSE 100’s gain of 4% over the same period. 

And I reckon this positive trend is going to continue throughout the rest of the year. Even though shares in Galliford have rallied, it still looks cheap to me. Galliford currently trades at a forward P/E of 7.6 and yields 6.7%. As investors continue to return, I think the stock will trade back up to its five-year average P/E of 10 – a potential upside of more than 25%!

Rupert Hargreaves does not own shares in Galliford Try.


Edward Sheldon: DS Smith

My top stock for October is packaging specialist DS Smith (LSE: SMDS). It currently trades on a forward P/E ratio of 12.8 and offers a prospective dividend yield of 3.4%.

Packaging is certainly not the most exciting investment theme yet, with the global boom in e-commerce, packaging companies look well placed to generate robust returns in the coming years, in my view. And FTSE 100 firm DS Smith – which counts Amazon (UK) as a key customer – appears to be performing well at present, with CEO Miles Roberts recently stating that the corrugated packaging industry continues to demonstrate “excellent growth prospects” as a result of changing shopping habits and e-commerce and that DS Smith is in a “strong position” to capitalise on these opportunities.

I see considerable value here at the current share price.

Edward Sheldon owns shares in DS Smith.


G A Chester: Hochschild Mining

Weak gold and silver prices this year have hurt sentiment towards precious metals miners like FTSE 250 firm Hochschild (LSE: HOC). This is a well-managed business with a strong balance sheet and, despite continuing good operational performance, its shares have felt the chill wind of a disinterested market.

I rate the stock a buy today on the basis that gold and silver prices won’t be depressed forever and that, even as things stand, with 75% earnings growth forecast for 2019 on the back of continuing increased production, Hochschild isn’t a company that will remain unloved for long, in my opinion.

G A Chester has no position in Hochschild.


Paul Summers: Central Asia Metals

My top pick is small-cap copper play Central Asia Metals (LSE: CAML). Thanks to the US/China trade shenanigans, many commodities – and the share prices of those producing them – have fallen heavily in price over recent months. Central Asia Metals is no exception.

Towards the end of last month, however, sentiment appeared to be changing, spurred on by repeated warnings about a forthcoming supply deficit of the red metal. There’s no way of telling whether this rally will last but, on 7 times earnings, the stock already seems cheap.

It’s also a cracking dividend payer, with this year’s expected 20 US cents per share return equating to a yield of well in excess of 6%.

Paul Summers has no position in Central Asia Metals


Peter Stephens: Imperial Brands 

The growth potential of next-generation products could catalyse the Imperial Brands (LSE: IMB) share price over the long run. The company is investing heavily in the segment, with its blu e-cigarette being a dominant brand. It expects sales and margins to improve over the next few years, while pricing power in its tobacco segment remains high.

Alongside this, Imperial Brands offers a wide margin of safety. Its shares have a P/E ratio of around 11, as well as a dividend yield of 7%. They ought to also offer defensive characteristics should the current bull market come to an end in the near term.

Peter Stephens owns shares in Imperial Brands.


Royston Wild: PageGroup 

The likelihood of another impressive trading update from PageGroup (LSE: PAGE) convinces me that now could be a great time to buy into the stock. Third-quarter financials are scheduled for October 8.

In its last update in August, the FTSE 250 recruiter advised that profits continued to rise by double-digit percentages in the first half of the fiscal year, driven by further impressive performance across its international businesses. Reports of additional progress since then could prompt a flurry of fresh buying activity from market makers following recent weakness.

A forward PEG reading of 1.1, created by City predictions of a 17% earnings jump in 2018, certainly leaves plenty of scope for new gains.

Royston Wild does not own shares in PageGroup.


Roland Head: BHP Billiton

My top buy in the commodity sector at the moment is Anglo-Australian group BHP Billiton (LSE: BLT).

Unlike its FTSE 100 rivals, BHP provides exposure to oil and gas as well as to key mining commodities such as copper and iron ore. Returns are high – this business generated a return on capital employed of 16% and an operating margin of 36% during the 12 months to 30 June.

Free cash flow clocked in at £9.6bn during the year, supporting a generous dividend. The shares now trade on 12 times forecast earnings with a prospective yield of 5.7%. I believe further gains are likely as the mining sector returns to growth.

Roland Head does not own shares of BHP Billiton.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool owns shares of and has recommended Amazon. The Motley Fool UK has recommended DS Smith and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »

Investing Articles

I’m expecting my Phoenix Group shares to give me a total return of 25% in 2025!

Phoenix Group shares have had a difficult few months but that doesn't worry Harvey Jones. He loves their 10%+ yield…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

14.5bn reasons why I think the Legal & General share price is at least 11% undervalued

According to our writer, the Legal & General share price doesn’t appear to reflect the underlying profitability of the business. 

Read more »